News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Here's Why The Best Is Yet To Come For Pfizer (PFE)



5/15/2017 6:20:04 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Pfizer, Inc. (NYSE:PFE) stock is lagging behind the S&P 500 Index so far in 2017. That's nothing new, though. Pfizer has underperformed the S&P 500 over the past year, the past three years, the past five years, and the past decade.

Despite this less-than-stellar track record, I bought Pfizer stock earlier this year. I'm counting on the drugmaker's future to be better than it's recent past. Here's why I think the best is yet to come for Pfizer.

Read at Motley Fool


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES